Why Choose Private Prescription for Weight Loss Medications?
Private vs NHS Routes: Mounjaro vs Wegovy for Weight Loss Access
The NHS pathway for accessing Mounjaro vs Wegovy for weight loss involves GP referral to specialist weight management services, often resulting in 6+ month waiting lists before initial consultation. Private prescription through EverydayMeds eliminates these delays entirely, offering direct access to qualified UK prescribers within 3 working days of your clinical assessment. You receive the same genuine medications - Novo Nordisk Wegovy and Eli Lilly Mounjaro - that NHS patients receive, but without the bureaucratic delays that can derail motivation for weight management.
Our private prescription model particularly benefits patients who meet clinical criteria but face postcode lottery restrictions or capacity constraints within their local NHS services. The streamlined process means you can begin your chosen treatment immediately once approved, maintaining momentum in your weight management journey rather than waiting months for specialist appointments that may not even result in prescription approval.
Wegovy vs Mounjaro Pricing: Transparent Private Prescription Costs
When comparing Mounjaro vs Wegovy for weight loss through private prescription, pricing transparency becomes crucial for treatment planning. Wegovy starts at £79.99 for the 0.25mg starter dose (weeks 1-4) with new customer code FIRST40, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg) to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide convenient dose progression, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, ensuring seamless treatment continuity.
Returning customers benefit from code DOSE25 at checkout, with bundle options designed for treatment stability rather than just cost savings. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, eliminating multiple ordering cycles. Mounjaro pricing varies by dose similarly, though specific costs depend on your prescriber's assessment and recommended treatment pathway when comparing both options.
Clinical Evidence: Mounjaro vs Wegovy for Weight Loss Effectiveness
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo in the landmark STEP 1 trial (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent results across different patient populations, including 9.6% average weight loss in patients with type 2 diabetes and sustained clinically studied weight loss at 2 years in STEP 5.
Mounjaro (tirzepatide) operates through a dual mechanism targeting both GIP and GLP-1 receptors, while Wegovy (semaglutide) specifically targets GLP-1 receptors only. Both medications showed significant cardiovascular benefits in their respective outcome trials, with Wegovy's SELECT trial demonstrating 20% reduction in major cardiovascular events. Direct comparison between trials isn't clinically appropriate due to different study designs and patient populations.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to support weight management alongside a reduced-calorie diet and increased physical activity. The medication works on brain appetite centres to reduce food cravings and promote feeling of fullness after smaller meals, helping patients maintain the caloric deficit necessary for sustainable weight loss. Once-weekly injection via the FlexTouch pen provides consistent medication levels throughout the week, eliminating daily dosing compliance issues common with oral weight management treatments. The dose escalation schedule from 0.25mg to 2.4mg over 16 weeks allows your body to adapt gradually, minimising potential gastrointestinal side effects while optimising therapeutic response. Clinical studies demonstrate that patients typically begin experiencing appetite changes within the first few weeks, with maximum weight loss effects generally observed after reaching the maintenance dose.
Private Prescription Process: From Assessment to Delivery
Our streamlined private prescription process for both Mounjaro vs Wegovy for weight loss begins with a comprehensive 3-minute online clinical assessment covering medical history, current medications, weight management goals, and contraindication screening. UK-qualified prescribers review your assessment within 3 working days (or 24 hours with express service), determining suitability for either medication based on MHRA licensing criteria and clinical guidelines. Once approved, your prescription-only medicine is dispensed from our GPhC-registered pharmacy #9012878 and shipped via next-day cold-chain delivery to maintain medication integrity. Temperature-controlled packaging ensures both Wegovy and Mounjaro arrive in optimal condition, with tracking provided for complete delivery transparency. Payment processing includes automatic application of discount codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout, with no hidden fees or subscription commitments beyond your chosen treatment plan.
Storage and Practical Considerations: Mounjaro vs Wegovy for Weight Loss
Storage requirements differ slightly between Mounjaro vs Wegovy for weight loss, with Wegovy offering superior travel convenience through 6 weeks room temperature stability once removed from refrigeration versus Mounjaro's 21-day limit. Both medications require refrigerated storage at 2-8°C before first use, but Wegovy's extended room temperature window provides greater flexibility for holidays, business travel, or temporary refrigeration disruptions. The FlexTouch pen design for Wegovy enables straightforward once-weekly self-injection, with clear dose escalation schedule from 0.25mg through 1.7mg to 2.4mg maintenance dosing. Dose escalation cannot be skipped or accelerated, ensuring optimal tolerance and therapeutic response throughout your weight management journey. Both medications integrate seamlessly into weekly routines, with many patients choosing consistent injection days (such as Sunday evenings) to maintain therapeutic scheduling alongside lifestyle commitments.
Treatment Selection: Personalised Mounjaro vs Wegovy for Weight Loss Decisions
Choosing between Mounjaro vs Wegovy for weight loss through private prescription depends on individual clinical factors, previous treatment responses, and lifestyle considerations that your prescriber evaluates during assessment. Wegovy's single GLP-1 receptor target offers proven weight management efficacy with extensive real-world safety data, while Mounjaro's dual GIP/GLP-1 mechanism may appeal to patients seeking alternative therapeutic approaches. Both medications are available from EverydayMeds, allowing your prescriber to recommend the most appropriate option based on your specific medical profile and weight management goals.
Private prescription access means you can discuss both options thoroughly with qualified prescribers without time pressures typical of NHS consultations, ensuring informed treatment selection. Some patients may trial one medication initially and switch to the alternative based on tolerance or effectiveness, a flexibility that private prescription facilitates more readily than NHS pathways with their stricter formulary restrictions and approval processes.
Start Your Weight Management Journey Today
Ready to begin comparing Mounjaro vs Wegovy for weight loss through private prescription? Complete our 3-minute clinical assessment to connect with UK prescribers who can evaluate your suitability for either medication based on MHRA criteria and clinical guidelines. New customers save with code FIRST40, while returning customers use DOSE25 at checkout for immediate access to transparent pricing without hidden fees. Our GPhC-registered pharmacy #9012878 ensures you receive genuine manufacturer medications with next-day delivery, bypassing NHS waiting lists that can delay treatment for months. Both Wegovy and Mounjaro represent evidence-based approaches to weight management when used alongside reduced-calorie diet and increased physical activity. Don't let NHS delays postpone your weight management goals - start your private prescription journey with professional support and convenient home delivery. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and take control of your weight management timeline today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
